Michelle A. Gourdine is Director at agilon health, inc. (AGL). They have made 1 open-market trade across 1 company since 2021, most recently 2022-04-14.
CIK 0001855956
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $115K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AGL | 18,892 | $1.6M |
Shares reported on the most recent Form 4, priced at the 2022-04-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AGL | BUY | 2021-04-19 | 2021-04-21 | $23.00 | $115K | +2.2% | +7.0% | +9.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.